NaviSci System
Early-Stage Lung Cancer (Soft Tissue Tumor Resection)
Feasibility Trial CompletedActive
Key Facts
Indication
Early-Stage Lung Cancer (Soft Tissue Tumor Resection)
Phase
Feasibility Trial Completed
Status
Active
Company
About Navigation Sciences
Navigation Sciences is a private, pre-revenue medical device company founded in 2016 and based in Brookline, MA (with a listed office in San Jose, CA). The company is developing the NaviSci System, an augmented reality-guided surgical platform that provides real-time, in-vivo margin measurement during soft tissue cancer resections. It has completed a 25-patient clinical feasibility trial in early-stage lung cancer to support an FDA submission and was recently selected as a 2025 'Best Start-up' candidate by the Prix Galien Foundation. The technology originated from Brigham & Women's Hospital and Harvard Medical School.
View full company profile